{"status": "ok", "totalResults": 7, "articles": [{"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": null, "name": "Ambcrypto.com"}, "author": "Dipayan Mitra", "title": "Bitcoin price prediction - Charting BTC's potential recovery from $62K to $71K - AMBCrypto News", "description": "Bitcoin dominance was rising once again as most altcoins have started shedding value in the bear market.", "url": "https://ambcrypto.com/from-62k-to-71k-charting-bitcoins-potential-recovery-path/", "urlToImage": "https://ambcrypto.com/wp-content/uploads/2024/04/Bitcoin-dominance-is-rising-1000x600.webp", "publishedAt": "2024-04-29T19:01:12Z", "content": "<ul><li>BTC was down by more than 5% in the last seven days.</li><li>BTCs price might plummet to 61k before turning bullish.</li></ul>After a sharp decline, Bitcoin [BTC] dominance started to increas\u2026 [+2511 chars]"}, {"source": {"id": null, "name": "Financial Times"}, "author": "Tom Wilson", "title": "Who are Anglo American's possible suitors? - Financial Times", "description": "The UK-listed miner has rejected an approach from BHP, but other bidders could emerge", "url": "https://www.ft.com/content/884d2bb0-57e8-4d82-b4b3-db314038e2a9", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fwww.ft.com%2F__origami%2Fservice%2Fimage%2Fv2%2Fimages%2Fraw%2Fhttps%253A%252F%252Fd1e00ek4ebabms.cloudfront.net%252Fproduction%252F66d10d29-e409-4ba6-95b4-eeb1c6882a73.jpg%3Fsource%3Dnext-article%26fit%3Dscale-down%26quality%3Dhighest%26width%3D700%26dpr%3D1?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2024-04-29T17:58:34Z", "content": "BHPs unsolicited \u00a331bn takeover approach for Anglo American has shaken up the mining industry, provoking speculation that the storied company is ripe to be sold or broken up.\r\nAnglo rejected the prel\u2026 [+5907 chars]"}, {"source": {"id": null, "name": "ForexLive"}, "author": "Adam Button", "title": "USD/JPY dip buyers wade in again - ForexLive", "description": "USD/JPY 5 mins There's no official confirmation that Japan's ministry of finance intervened today but there are certainly tell-tale signs.", "url": "https://www.forexlive.com/news/usdjpy-dip-buyers-wade-in-again-20240429/", "urlToImage": "https://images.forexlive.com/images/USDJPY%205%20mins_id_40ed1030-b723-4a78-8ee4-38244ebcdcdb_size975.jpg", "publishedAt": "2024-04-29T17:52:00Z", "content": "High risk warning:\r\nForeign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade fo\u2026 [+2129 chars]"}, {"source": {"id": null, "name": "[Removed]"}, "author": null, "title": "[Removed]", "description": "[Removed]", "url": "https://removed.com", "urlToImage": null, "publishedAt": "1970-01-01T00:00:00Z", "content": "[Removed]"}, {"source": {"id": "fortune", "name": "Fortune"}, "author": "Ryan Hogg", "title": "EU's unwinnable EV price war: BYD cars 11 times more profitable in Europe than in China - Fortune", "description": "Only a highly unlikely 50% import tariff would be enough to deter Chinese automakers from Europe, new research finds.", "url": "https://fortune.com/europe/2024/04/29/eu-unwinnable-price-war-chinese-evs-byd-cars-11-times-more-profitable-in-europe-than-in-china/", "urlToImage": "https://fortune.com/img-assets/wp-content/uploads/2024/04/GettyImages-1926876968-e1714385648949.jpg?resize=1200,600", "publishedAt": "2024-04-29T10:48:00Z", "content": "As a fleet of vessels ship ultra-cheap electric vehicles like BYD into Europe from China, helpless European carmakers have watched on begging for regulators to save them from a price war they cant po\u2026 [+3754 chars]"}, {"source": {"id": null, "name": "Astrazeneca.com"}, "author": null, "title": "Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low metastatic breast cancer following one or more lines of endocrine therapy in DESTINY-Breast06 Phase III trial - AstraZeneca", "description": "", "url": "https://www.astrazeneca.com/media-centre/press-releases/2024/enhertu-improved-pfs-in-her2-low-and-ultralow.html", "urlToImage": "", "publishedAt": "2024-04-29T01:30:00Z", "content": "Positive high-level results from the DESTINY-Breast06 Phase III trial showed that Enhertu (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in pr\u2026 [+12518 chars]"}]}